• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺乏Brca1的情况下,ATM-Chk2-p53激活以牺牲器官稳态为代价预防肿瘤发生。

ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.

作者信息

Cao Liu, Kim Sangsoo, Xiao Cuiying, Wang Rui-Hong, Coumoul Xavier, Wang Xiaoyan, Li Wen Mei, Xu Xiao Ling, De Soto Joseph A, Takai Hiroyuki, Mai Sabine, Elledge Stephen J, Motoyama Noboru, Deng Chu-Xia

机构信息

Genetics of Development and Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

EMBO J. 2006 May 17;25(10):2167-77. doi: 10.1038/sj.emboj.7601115. Epub 2006 May 4.

DOI:10.1038/sj.emboj.7601115
PMID:16675955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1462967/
Abstract

BRCA1 is a checkpoint and DNA damage repair gene that secures genome integrity. We have previously shown that mice lacking full-length Brca1 (Brca1(delta11/delta11)) die during embryonic development. Haploid loss of p53 completely rescues embryonic lethality, and adult Brca1(delta11/delta11)p53+/- mice display cancer susceptibility and premature aging. Here, we show that reduced expression and/or the absence of Chk2 allow Brca1(delta11/delta11) mice to escape from embryonic lethality. Compared to Brca1(delta11/delta11)p53+/- mice, lifespan of Brca1(delta11/delta11)Chk2-/- mice was remarkably extended. Analysis of Brca1(delta11/delta11)Chk2-/- mice revealed that p53-dependent apoptosis and growth defect caused by Brca1 deficiency are significantly attenuated in rapidly proliferating organs. However, in later life, Brca1(delta11/delta11)Chk2-/- female mice developed multiple tumors. Furthermore, haploid loss of ATM also rescued Brca1 deficiency-associated embryonic lethality and premature aging. Thus, in response to Brca1 deficiency, the activation of the ATM-Chk2-p53 signaling pathway contributes to the suppression of neoplastic transformation, while leading to compromised organismal homeostasis. Our data highlight how accurate maintenance of genomic integrity is critical for the suppression of both aging and malignancy, and provide a further link between aging and cancer.

摘要

BRCA1是一个确保基因组完整性的检查点和DNA损伤修复基因。我们之前已经表明,缺乏全长Brca1的小鼠(Brca1(delta11/delta11))在胚胎发育期间死亡。p53单倍体缺失完全挽救了胚胎致死性,成年Brca1(delta11/delta11)p53+/-小鼠表现出癌症易感性和早衰。在这里,我们表明Chk2表达降低和/或缺失使Brca1(delta11/delta11)小鼠能够逃避胚胎致死性。与Brca1(delta11/delta11)p53+/-小鼠相比,Brca1(delta11/delta11)Chk2-/-小鼠的寿命显著延长。对Brca1(delta11/delta11)Chk2-/-小鼠的分析表明,由Brca1缺陷引起的p53依赖性凋亡和生长缺陷在快速增殖的器官中显著减弱。然而,在晚年,Brca1(delta11/delta11)Chk2-/-雌性小鼠发生了多种肿瘤。此外,ATM单倍体缺失也挽救了与Brca1缺陷相关的胚胎致死性和早衰。因此,响应Brca1缺陷,ATM-Chk2-p53信号通路的激活有助于抑制肿瘤转化,同时导致机体稳态受损。我们的数据突出了基因组完整性的精确维持对于抑制衰老和恶性肿瘤的关键作用,并提供了衰老与癌症之间的进一步联系。

相似文献

1
ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.在缺乏Brca1的情况下,ATM-Chk2-p53激活以牺牲器官稳态为代价预防肿瘤发生。
EMBO J. 2006 May 17;25(10):2167-77. doi: 10.1038/sj.emboj.7601115. Epub 2006 May 4.
2
A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency.在对由Brca1缺陷诱导的基因组不稳定性的生物学反应中对53BP1的选择性需求。
Mol Cell. 2009 Aug 28;35(4):534-41. doi: 10.1016/j.molcel.2009.06.037.
3
ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.顺铂诱导细胞凋亡过程中ATR-Chk2信号通路在p53激活及DNA损伤反应中的作用
J Biol Chem. 2008 Mar 7;283(10):6572-83. doi: 10.1074/jbc.M707568200. Epub 2007 Dec 27.
4
STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.信号转导和转录激活因子1(STAT-1)在DNA损伤后促进共济失调毛细血管扩张突变基因(ATM)激活的检查点通路。
J Cell Sci. 2005 Apr 15;118(Pt 8):1629-39. doi: 10.1242/jcs.01728. Epub 2005 Mar 22.
5
Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.H2AX、NBS1和p53在ATM依赖性DNA损伤反应和肿瘤抑制中的功能相互作用。
Mol Cell Biol. 2005 Jan;25(2):661-70. doi: 10.1128/MCB.25.2.661-670.2005.
6
Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1.携带有 Brca1 中 S1152-ATM 磷酸化位点突变的小鼠皮肤和乳腺发育受损,并增加了 γ 射线诱导的肿瘤发生。
Cancer Res. 2009 Dec 15;69(24):9291-300. doi: 10.1158/0008-5472.CAN-09-2418.
7
Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure.Brca1与Gadd45a在中心体复制、遗传稳定性和神经管闭合中的遗传相互作用。
J Biol Chem. 2004 Jul 9;279(28):29606-14. doi: 10.1074/jbc.M312279200. Epub 2004 May 3.
8
BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.电离辐射诱导的DNA损伤后,p53丝氨酸15位点磷酸化及G1/S期阻滞需要BRCA1-BARD1复合物。
J Biol Chem. 2004 Jul 23;279(30):31251-8. doi: 10.1074/jbc.M405372200. Epub 2004 May 24.
9
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.Chk2是一种肿瘤抑制因子,它以依赖共济失调毛细血管扩张症突变基因(ATM)和不依赖ATM的方式调节细胞凋亡。
Mol Cell Biol. 2002 Sep;22(18):6521-32. doi: 10.1128/MCB.22.18.6521-6532.2002.
10
Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.三氧化二砷通过抑制致癌性Wip1磷酸酶增强Chk2/p53介导的细胞凋亡。
J Biol Chem. 2008 Jul 4;283(27):18969-79. doi: 10.1074/jbc.M800560200. Epub 2008 May 15.

引用本文的文献

1
Manganese mediates antiviral effects by driving an ATM -TBK1 phosphorylation signaling pathway.锰通过驱动ATM-TBK1磷酸化信号通路介导抗病毒作用。
bioRxiv. 2025 Aug 23:2025.08.20.671272. doi: 10.1101/2025.08.20.671272.
2
Mapping the current research landscape of metformin in cancer based on bibliometric analysis.基于文献计量分析绘制二甲双胍在癌症领域的当前研究全景图。
Discov Oncol. 2025 Aug 11;16(1):1522. doi: 10.1007/s12672-025-03327-z.
3
ATM and p53 in aging and cancer: a double-edged sword in genomic integrity.衰老与癌症中的ATM和p53:基因组完整性中的双刃剑
Biogerontology. 2025 May 5;26(3):102. doi: 10.1007/s10522-025-10249-4.
4
The involvement of cyclin-dependent kinase 7 (CDK7) and 9 (CDK9) in coordinating transcription and cell cycle checkpoint regulation.细胞周期蛋白依赖性激酶7(CDK7)和9(CDK9)在协调转录和细胞周期检查点调控中的作用。
Cell Cycle. 2024 Nov-Dec;23(21-24):962-974. doi: 10.1080/15384101.2025.2485844. Epub 2025 Apr 14.
5
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy.SMYD3-SHCBP1的致癌激活促进乳腺癌发展,并与免疫治疗耐药相关。
Cell Death Dis. 2025 Mar 29;16(1):220. doi: 10.1038/s41419-025-07570-8.
6
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition.代谢依赖性图谱确定过氧化物酶1是对ATM抑制产生抗性的驱动因素。
Redox Biol. 2025 Mar;80:103503. doi: 10.1016/j.redox.2025.103503. Epub 2025 Jan 19.
7
BRCA1 is involved in sustaining rapid antler growth possibly via balancing of the p53/endoplasmic reticulum stress signaling pathway.BRCA1可能通过平衡p53/内质网应激信号通路参与维持鹿茸的快速生长。
Biol Direct. 2025 Jan 24;20(1):13. doi: 10.1186/s13062-025-00606-1.
8
Guarding against digestive-system cancers: Unveiling the role of Chk2 as a potential therapeutic target.预防消化系统癌症:揭示Chk2作为潜在治疗靶点的作用。
Genes Dis. 2023 Dec 7;12(1):101191. doi: 10.1016/j.gendis.2023.101191. eCollection 2025 Jan.
9
Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research.解析细胞衰老与恶性转化之间的关系:癌症研究中的范式转变。
Cancer Biol Med. 2024 Jun 25;21(7):541-6. doi: 10.20892/j.issn.2095-3941.2024.0157.
10
Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.基于整合生物信息学的方法鉴定和临床病理分析结直肠癌中潜在的 p73 调控生物标志物
Sci Rep. 2024 Apr 30;14(1):9894. doi: 10.1038/s41598-024-60715-1.

本文引用的文献

1
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.乳腺癌1号基因(BRCA1):细胞周期检查点、基因不稳定、DNA损伤反应与癌症演变
Nucleic Acids Res. 2006 Mar 6;34(5):1416-26. doi: 10.1093/nar/gkl010. Print 2006.
2
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.p53 依赖的细胞衰老在抑制 Pten 缺陷肿瘤发生中的关键作用。
Nature. 2005 Aug 4;436(7051):725-30. doi: 10.1038/nature03918.
3
BRAFE600-associated senescence-like cell cycle arrest of human naevi.BRAF V600相关的人类痣细胞类似衰老的细胞周期停滞
Nature. 2005 Aug 4;436(7051):720-4. doi: 10.1038/nature03890.
4
Oncogene-induced senescence as an initial barrier in lymphoma development.癌基因诱导的衰老作为淋巴瘤发展的初始屏障。
Nature. 2005 Aug 4;436(7051):660-5. doi: 10.1038/nature03841.
5
Tumour biology: senescence in premalignant tumours.肿瘤生物学:癌前肿瘤中的细胞衰老
Nature. 2005 Aug 4;436(7051):642. doi: 10.1038/436642a.
6
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.人类癌前病变中DNA损伤检查点的激活与基因组不稳定
Nature. 2005 Apr 14;434(7035):907-13. doi: 10.1038/nature03485.
7
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.DNA损伤反应作为人类早期肿瘤发生过程中潜在的抗癌屏障。
Nature. 2005 Apr 14;434(7035):864-70. doi: 10.1038/nature03482.
8
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.衰老细胞、肿瘤抑制与机体衰老:良民,恶邻
Cell. 2005 Feb 25;120(4):513-22. doi: 10.1016/j.cell.2005.02.003.
9
DNA repair, genome stability, and aging.DNA修复、基因组稳定性与衰老。
Cell. 2005 Feb 25;120(4):497-512. doi: 10.1016/j.cell.2005.01.028.
10
Cell-cycle checkpoints and cancer.细胞周期检查点与癌症。
Nature. 2004 Nov 18;432(7015):316-23. doi: 10.1038/nature03097.